Osaka, Japan

Kenji Kono

This inventor holds 2 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Osaka Prefecture University, Nof Corporation. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kenji Kono. Retrieved from https://idiyas.com/inventor/kenji-kono-vjwfx0e4

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 50.0

 

Average Co-Inventor Count = 1.6

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Osaka, JP (2013)
  • Sakai, JP (2013)

Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kenji Kono: Innovator in Phospholipid Derivatives

Introduction

Kenji Kono is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of phospholipid derivatives and liposomal technology. His innovative work has implications for various applications in drug delivery and medical research.

Latest Patents

Kenji Kono holds a patent for a phospholipid derivative and pH-responsive liposomes. This patent describes a phospholipid derivative represented by a specific formula, along with a liposome containing this derivative. The innovation aims to enhance the effectiveness of drug delivery systems.

Career Highlights

Throughout his career, Kenji Kono has worked with reputable organizations, including Nof Corporation and Osaka Prefecture University Public Corporation. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Kenji Kono has collaborated with notable colleagues such as Masaya Arai and Kazuhiro Kubo. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Kenji Kono's work in phospholipid derivatives and liposomal technology showcases his dedication to advancing biochemistry. His contributions are valuable to the fields of drug delivery and medical research, highlighting the importance of innovation in science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…